Sr. Manager - Global Cyber - Tactical Defense Operations at Eli Lilly and Company

Cork, County Cork, Ireland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Experience in tactical operations within cybersecurity defense, particularly in global cyber defense operations
Leadership skills to manage functional groups including Attack Surface Management, Cyber Threat Intelligence, Detection and Automation Operations, Cyber Defense Readiness, External Threat Response, and Insider Threat Response
Expertise in monitoring, detection, analysis, investigation, and response to cybersecurity events and incidents (External Threat Response)
Knowledge of reducing enterprise attack surface through identification, analysis, and remediation of vulnerabilities (Attack Surface Management)
Proficiency in consuming, contributing, producing, and evangelizing threat intelligence, including understanding threats, attack campaigns, and intrusion sets (Cyber Threat Intelligence)
Ability to integrate key initiatives between GCDO and other cybersecurity/business partners (Cyber Defense Readiness)
Skills in SecOps and DevOps for detection and analysis capabilities (Detection and Analysis Operations)

Responsibilities

Oversee all tactical operations of the Global Cyber Defense Operations (GCDO) team
Manage functional groups: Attack Surface Management, Cyber Threat Intelligence, Detection and Automation Operations, Cyber Defense Readiness, External Threat Response, and Insider Threat Response
Lead monitoring, detection, analysis, investigation, and response to cybersecurity events and incidents (External Threat Response)
Direct efforts to reduce the enterprise attack surface, including vulnerability identification, analysis, and remediation (Attack Surface Management)
Lead organization-wide efforts to consume, contribute, produce threat intelligence, and maintain understanding of threats, campaigns, and intrusion sets targeting Lilly (Cyber Threat Intelligence)
Integrate key initiatives between GCDO and Cybersecurity/business partners (Cyber Defense Readiness)
Manage SecOps and DevOps for GCDO-owned detection and analysis capabilities (Detection and Analysis Operations)

Skills

Cybersecurity

Tactical Defense

Operations Management

Global Security

Incident Response

Threat Detection

Security Operations

Risk Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free